COVID-19 pneumonia: pathophysiology and management
L Gattinoni, S Gattarello, I Steinberg… - European …, 2021 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) pneumonia is an evolving disease. We will focus on
the development of its pathophysiologic characteristics over time, and how these time …
the development of its pathophysiologic characteristics over time, and how these time …
[HTML][HTML] Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS
DL Grieco, SM Maggiore, O Roca, E Spinelli… - Intensive care …, 2021 - Springer
The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …
Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
Noninvasive respiratory support for adults with acute respiratory failure
Noninvasive Respiratory Support in Acute Respiratory Failure Noninvasive respiratory
support can be useful for cardiogenic pulmonary edema and COPD exacerbations. For other …
support can be useful for cardiogenic pulmonary edema and COPD exacerbations. For other …
[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review
CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …
High-flow nasal cannula and COVID-19: a clinical review
C Crimi, P Pierucci, T Renda, L Pisani… - Respiratory Care, 2022 - rc.rcjournal.com
During the coronavirus disease 2019 (COVID-19) pandemic, noninvasive respiratory
support has played a central role in managing patients affected by moderate-to-severe acute …
support has played a central role in managing patients affected by moderate-to-severe acute …
[HTML][HTML] S2k-Leitlinie–Empfehlungen zur stationären Therapie von Patienten mit COVID-19
S Kluge, U Janssens, T Welte, S Weber-Carstens… - …, 2021 - thieme-connect.com
Seit Dezember 2019 verbreitet sich das neuartige Coronavirus SARS-CoV-2 (Severe Acute
Respiratory Syndrome–Corona Virus-2) rasch im Sinne einer weltweiten Pandemie. Dies …
Respiratory Syndrome–Corona Virus-2) rasch im Sinne einer weltweiten Pandemie. Dies …
High-flow nasal oxygen for severe hypoxemia: oxygenation response and outcome in patients with COVID-19
Rationale: The “Berlin definition” of acute respiratory distress syndrome (ARDS) does not
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …
Noninvasive respiratory support following extubation in critically ill adults: a systematic review and network meta-analysis
Purpose Systematic review and network meta-analysis to investigate the efficacy of
noninvasive respiratory strategies, including noninvasive positive pressure ventilation …
noninvasive respiratory strategies, including noninvasive positive pressure ventilation …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …